2nd Quarter - Amendment

TIBER CREEK GROUP for AMGEN INC

Firm
Client
Income
$80,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 20, 2009 $80,000 Replaced
2nd Quarter - Amendment (this page) Jul 14, 2011 $80,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Follow-on biologics. H.R. 1427/S. 726, the Promoting Innovation and Access to Life Saving Medicines Act. H.R.1548, Pathway for Biosimilars Act. Affordable Health Choices Act.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ CoS, Representative Bean
JONATHON JONES —
SHEILA MURPHY LD, Sen. Klobuchar

Contacted: SENATE

Bills named: H.R. 1548 (111th), H.R. 1427 (111th), S. 726 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.